Utama › Kanser (semua jenis) › Oklahoma › Oklahoma City
Kajian klinikal Kanser (semua jenis) di Oklahoma City, OK
14 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Oklahoma City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Mengambil pesertaFasa 2
- OU Health - Stephenson Cancer Center /ID# 277656, Oklahoma City
Registry Study for Radiation Therapy Outcomes
Mengambil pesertaKajian pemerhatian
- Oklahoma Proton Center, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- University of Oklahoma, Oklahoma City
Prospective Study to Assess a Diagnostic Aid for Cancer
Mengambil pesertaKajian pemerhatian
- Hightower Clinical, Oklahoma City
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Mengambil pesertaFasa 2/3
- University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Mengambil pesertaFasa 1
- OU Health Stephenson Cancer Center, Oklahoma City
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Mengambil pesertaKajian pemerhatian
- Mercy Hospital - OKC, Oklahoma City
GEMINI-NSCLC: NSCLC Biomarker Study
Mengambil pesertaKajian pemerhatian
- Hightower Clinical, Oklahoma City
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Mengambil pesertaFasa 2
- Oklahoma University Stephenson Cancer Center, Oklahoma City
A Study of NX-1607 in Adults With Advanced Malignancies
Mengambil pesertaFasa 1
- University of Oklahoma, Oklahoma City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Mengambil pesertaKajian pemerhatian
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Mengambil peserta
- OUHSC Stephenson Cancer Center, Oklahoma City
- Mercy Health Center - Oncology Hematology, Oklahoma City
Kajian Kanser (semua jenis) di bandar lain
- Houston, TX121 kajian
- New York City, NY110 kajian
- Boston, MA86 kajian
- Los Angeles, CA73 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Durham, NC58 kajian
- Washington, DC58 kajian
- Chicago, IL51 kajian
- Seattle, WA49 kajian
- Atlanta, GA49 kajian
- Arlington, VA48 kajian
Kajian lain di Oklahoma City
- Kanser Paru-paru Bukan Sel Kecil28 kajian
- Kanser Ovari28 kajian
- Kanser Endometrium25 kajian
- Kanser Kolorektal22 kajian
- Kanser Prostat21 kajian
- Kanser Paru-paru19 kajian
- Kanser Payudara17 kajian
- Kanser Metastatik15 kajian
- Leukemia Mieloid Akut14 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher13 kajian
- Kanser Pankreas11 kajian
- Kanser Pundi Kencing11 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.